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Total hip replacementAbstract Background: The aim of this study was to investigate the effect of intravenous infusion
vs intrathecal magnesium sulfate during spinal anesthesia on postoperative pain, analgesic con-
sumption, and intraoperative blood loss on patients undergoing total hip arthroplasty surgery.
Methods: In this prospective randomized controlled study, 75 adult patients, ASA physical status I
and II scheduled for total hip arthroplasty, were included and randomized into three groups. Patients
inGroup I (control) received spinal anesthesia with hyperbaric bupivacaine and fentanyl. InGroup II
(IT Mg), 50 mg of magnesium sulfate was added to bupivacaine and fentanyl. In Group III (IV Mg),
after inductionof spinal anesthesia as in group I, a bolus doseof i.v.magnesium sulfate 40 mg kg1was
injectedover10 min, followedbycontinuous infusionof15 mg kg1 h1 till the endof surgery.Arterial
blood pressure, heart rate, electrocardiography, and O2 saturation were continuously monitored.
Onset, duration of sensory andmotor block, and postoperative pain scores were assessed. Serummag-
nesium concentrations were checked before induction of anesthesia, immediately after surgery, at 6 h
and 24 h after surgery. Total analgesic consumption and intraoperative blood loss were calculated.
Results: There were no signiﬁcant differences between the study groups in terms of onset time and
maximum sensory level achieved, as well as onset and duration of motor block. Postoperative pain
scores and 24 h analgesic consumption were lower in group II and III with insigniﬁcant differences
between them. Intraoperative blood loss was signiﬁcantly lower in group III. PostoperativeMg levels
were higher in group III, without signiﬁcant side effects.
Conclusions: Both i.v. infusion and intrathecal injection ofMg sulfate improved postoperative analge-
sia after total hip replacement. In addition, i.v. infusion ofMg sulfate reduced intraoperative blood loss.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.D license.1. Introduction
Postoperative pain following total hip replacement arthro-
plasty is usually moderate to severe in nature. Adequate post-
operative pain management is essential for early rehabilitation
[1,2].
396 E.M. Samir et al.Magnesium (Mg) is an inorganic ion that has a non-com-
petitive N-methyl-D-aspartate (NMDA) receptor antagonist
property with antinociceptive effects in animals and human
models [3,4]. Magnesium has been used as an anticonvulsant
for the treatment of preterm labor, preeclampsia and eclamp-
sia, myocardial protection after ischemia, hemodynamic stabil-
ity during endotracheal intubation, and severe attacks of
bronchial asthma [5,6].
Magnesium acts as a stabilizer for the cell membrane and
intracytoplasmic organelles through intervention in the activa-
tion of membrane Ca ATPase and Na-K ATPase involved in
the transmembrane exchange of ions during depolarization
and repolarization phases. Mg also inhibits the outﬂow of
Ca from the sarcoplasmic reticulum through its effect on L-
type calcium channels in the membranes and sarcoplasmic
reticulum. In addition, Mg has a vasodilator effect by increas-
ing the synthesis of prostacyclin and inhibiting the activity of
angiotensin-converting enzyme. A dose dependent myocardial
depressant effect of Mg has been reported [7,8].
Previous studies have demonstrated that Mg sulfate infu-
sion during general anesthesia shorten the induction time by
propofol, reduced anesthetic requirement as well as the post-
operative analgesic consumption [9,10]. Other studies, how-
ever, suggested that perioperative administration of Mg had
little effect on postoperative pain [11,12]. The effect of Mg sul-
fate during spinal anesthesia either as an adjuvant to intrathe-
cal bupivacaine or as intravenous infusion started immediately
after the induction of spinal anesthesia has not been fully
established.
Accordingly, the aim of this prospective randomized study
was to evaluate the effect of supplementary i.v. infusion of
magnesium sulfate vs intrathecal magnesium during spinal
anesthesia on postoperative pain, analgesic consumption,
and intraoperative blood loss in patients undergoing total
hip replacement surgery.2. Methods
Following Institutional Ethical Committee approval and in-
formed written consent from each patient, 75 adult patients
American Society of Anesthesiologists (ASA) physical status
I and II undergoing unilateral total hip arthroplasty were en-
rolled in this prospective randomized controlled study. Exclu-
sion criteria included bleeding disorders, cardiac, renal or
hepatic dysfunction, neuromuscular diseases, opioid abuse,
known allergy to the medications used, and treatment with cal-
cium channel blockers. The study was conducted at Kasr El
Aini hospitals, and patients were recruited in the period be-
tween January 2011 and May 2012.
Patients were randomly assigned to one of three groups (25
patients each) using closed envelopes. On arrival to the operat-
ing theater, each patient received 500 mL of Ringer’s solution
over 10–15 min. Standard monitoring including electrocardi-
ography (ECG), pulse oximetry, and noninvasive blood pres-
sure was applied.
After obtaining baseline values of hemodynamic variables,
spinal anesthesia was performed in the lateral decubitus posi-
tion using Quincke spinal needle 25 G inserted via a midline
approach through the L3–4 or L4–5 interspace under proper
aseptic conditions with the surgical side down. 12–15 mgHyperbaric bupivacaine (Astra Zeneca, Sweden) and solution
with 0.5 mL (25 mcg) fentanyl were injected intrathecally in
all patients of Group I (control) (n= 25). The dose of Bupiv-
acaine was based on patients’ height (<155 cm = 12 mg, 155–
170 cm = 13 mg, 170–180 cm = 14 mg, 180 cm = 15 mg) [13].
InGroup II (ITMg) (n= 25), 0.5 mL (50 mg) ofmagnesium
sulfate was added to the previous mixture before intrathecal
injection in all patients of this group. In Group III (IV Mg)
(n= 25), the same dose of bupivacaine and fentanyl were in-
jected intrathecally as in group I, a bolus dose ofmagnesium sul-
fate 40 mg kg1 in 100 mL of isotonic saline was infused i.v. to
all patients of this group over 10 min after a stable block level
andhemodynamic status, andbefore the start of the surgery, fol-
lowed by continuous infusion of 15 mg kg1 h1 till the end of
surgery.
Immediately after intrathecal injection of the local anes-
thetic, patients were turned into the supine position. Oxygen
3 L/min was applied to all patients via nasal prongs. Mean
arterial pressure was monitored every 5 min intraoperatively
and every 10 min in the postanesthesia care unit (PACU)
and recorded at the following times: before induction (base line
T0), immediately after spinal anesthesia (T1), and at 5, 10, 15,
30, 60, 90, 120 min thereafter, and at 30 min, 1, 4, 12, and 24 h
after surgery (T2–T13). Hypotension (systolic blood pressur-
e < 90 mmHg or mean arterial pressure decreased
by > 20% from baseline) was treated with a bolus dose of
ephedrine 5 mg and ﬂuid as indicated. Atropine 0.5 mg was gi-
ven to treat bradycardia (HR< 50 b/min).
Bilateral sensory block to pinprick was tested in a cephalad
to caudal direction in the midclavicular line bilaterally, mea-
surements included the onset (time from intrathecal injection
of drugs to reach T10 sensory level), highest dermatome level
achieved, and the duration of sensory block (time from peak
of sensory block till regression to S1).
Motor blockade of the lower extremity muscles was as-
sessed using Bromage Score: (0 = no motor block, ability
to raise hips, knees, and ankles. 1 = unable to raise ex-
tended legs, able to move knees and feet. 2 = unable to
raise extended leg or move knee; able to move feet. 3 = un-
able to move any part of the lower limbs) [14] measurements
included the onset (time from induction of spinal anesthesia
till Bromage = 3) and duration (time from complete block
till Bromage = 0).
At the end of surgery, patients were transferred to the
PACU. The level of pain based on visual analog scale (VAS)
(where 0 = no pain and 10 = worst pain) was assessed imme-
diately after surgery, 1 h, 2 h, 6 h, 12 h, and 24 h after surgery.
Patients were also assessed for side effects as nausea, vom-
iting, bradycardia, and hypotension.
Intraoperative blood loss was estimated based on the
amount of blood in the suction container and the difference
in weights between the dry and blood soaked towels.
Preoperative serum Mg level was checked in each patient,
and then, blood samples for measuring serum Mg were ob-
tained immediately postoperative, at 6 and 24 h after surgery.
A standard postoperative analgesia was performed using
i.v. ketorolac 30 mg/6 h and i.v. paracetamol 1 gm/6 h. Meper-
idine 50 mg i.m was given whenever VAS > 3. Meperidine was
also given whenever needed by the patient in between the
assessment visits, provided that 4 h at least should be passed
since the last dose.
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Figure 1 Perioperative mean arterial pressure (mmHg). GI
(control); GII (IT Mg); Group III (IV Mg). T0 (before induction);
T1 (postinduction); T2 (5 min); T3 (10 min); T4 (15 min); T5
(30 min); T6 (60 min); T7 (90 min); T8(120 min); T9 (30 min
postoperative); T10(1 h postoperative); T11(4 h postoperative);
T12(12 h postoperative); T13 (24 h postoperative); \statistically
signiﬁcant compared to group I and II.
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Figure 2 Perioperative heart rate (Beat/min). GI (control); GII
(IT Mg); Group III (IV Mg). T0 (pre induction); T1 (postinduc-
tion); T2 (5 min); T3 (10 min); T4 (15 min); T5 (30 min); T6
(60 min); T7 (90 min); T8(120 min); T9 (30 min postoperative);
T10(1 h postoperative); T11(4 h postoperative); T12(12 h postop-
erative); T13 (24 h postoperative).
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well as the total meperidine consumption in the ﬁrst 24 h
postoperative.
2.1. Statistical analysis
Statistical analysis was done using Prism 5.0a (GraphPad Soft-
ware, Inc.). Data were expressed as mean (SD), median, and
range or ratio as indicated. One-way analysis of variance (AN-
OVA) was used for comparisons between groups. Categorical
variables were compared using the Chi-square test. A p value
of <0.05 was considered statistically signiﬁcant.
3. Results
There were no signiﬁcant differences as regard age, height,
body weight, and operative time between the three study
groups (Table 1).
Baseline MAP and HR were insigniﬁcantly different in the
three groups. However, MAP values were signiﬁcantly lower
in group III compared to the other 2 groups at 30 min after
spinal anesthesia and up to 1 h postoperative (Fig. 1). Three pa-
tients in group III developed intraoperative hypotension which
was treated with ephedrine 5 mg and ﬂuid (250 mL of Ringer’s
solution) boluses.HRvariables were insigniﬁcantly different be-
tween the three study groups throughout the study (Fig. 2). Two
patients in group III compared to one patient in group I and an-
other one in group II had bradycardia, and the HR dropped be-
low 50/min and returned to normal value after atropine 0.5 mg.
The SpO2 was higher than 95% in all patients of the three
groups, either during surgery or in the PACU.
Insigniﬁcant differences were recorded between the three
study groups as regard onset of sensory blockade and, the
maximal dermatome height achieved. Time to two segment
regression and the duration of sensory blockade were signiﬁ-
cantly shorter among patients of group I compared to group
II and III with insigniﬁcant differences between them
(Table 2).
The mean onset time and the time to complete recovery of
motor blockade were insigniﬁcantly different between the 3
study groups (Table 2).
The pain scores (VAS) were signiﬁcantly lower in group II
and III compared to group I at 2 h, 6 h, and 12 h postopera-
tive. Insigniﬁcant differences between group II and III were re-
corded throughout the study (Table 3).
The time to ﬁrst analgesic request was prolonged signiﬁ-
cantly in group II and III compared to group I. In addition,Table 1 Demographic and operative data {mean (SD) and ratio}.
Group I (control)
(n= 25)
Age (years) 63.04(4.49)
Weight (kg) 76.1(4.3)
Height (cm) 167(9.4)
Sex (male/female) 12/13
Duration of surgery (min) 118(16.3)
Intraoperative blood loss (mL) 790(66.14)
IT = intrathecal, IV = intravenous.
* Statistically signiﬁcant compared to group I and II.the total postoperative 24 h meperidine requirement was
signiﬁcantly higher in group I compared to the other 2 groups
(Table 4).Group II (IT Mg) Group III (IV Mg)
(n= 25) (n= 25)
64.8(2.29) 62.72(2.57)
78.6(6.02) 79.2(4.7)
165(8.7 164(11.7)
14/11 12/13
126(10.02) 122(11.7)
778(75.11) 428(57.88)*
Table 2 Onset and duration of sensory and motor block in the study groups {mean (SD) and median and range}.
Group I (control) Group II (IT Mg) Group III (IV Mg) P value
(n= 25) (n= 25) (n= 25)
Sensory blockade
Onset (Time to reach T10) (min) 4.78(0.78) 4.97(0.74) 5.0(0.69) 0.5492
Maximum sensory level T5 (T4–T6) T6 (T5–T7) T5 (T4–T6) 0.0925
Time to Two segment regression (min) 77.84(8.65)* 127.2(10.32) 131.6(11.46) 0.0001
Duration (min) 227.1(16.26)* 299.7(18.31) 303.7(21.77) 0.0001
Motor blockade
Onset (Time to Bromage = 3) (min) 7.68(0.70) 6.72(2.97) 7.34(0.80) 0.1288
Duration (Time to Bromage = 0) (min) 193.8(21.42) 200.4(11.81) 198.1(24.03) 0.6695
IT = intrathecal, IV = intravenous.
* Statistically signiﬁcant compared to group II and III.
Table 3 Postoperative VAS at different times of the study {median (rang)}.
Group I (control) Group II (ITMg) Group III (IV Mg)
(n= 25) (n= 25) (n= 25)
Immediate postoperative 0 (0–2) 0 (0–1) 0 (0–1)
1 h Postoperative 0 (0–3) 0 (0–2) 0 (0–2)
2 h Postoperative 4 (3–5)* 2 (0–3) 2 (0–2)
6 h Postoperative 5 (4–6)* 3 (2–4) 3 (1–4)
12 h Postoperative 4 (3–5)* 1 (0–3) 1 (0–2)
24 h Postoperative 2 (2–3) 2 (1–3) 2 (1–3)
VAS = Visual Analog Score, IT = intrathecal, IV = intravenous.
* Statistically signiﬁcant compared to group II and III (p< 0.05).
Table 4 Time for ﬁrst analgesic request and total postoperative 24 h meperidine consumption [mean (SD)].
Group I (Control) Group II (IT Mg) Group III (IV Mg)
(n= 25) (n = 25) (n= 25)
Time for 1st. analgesic request (min) 185 (6.44)* 242 (9.78) 238 (9.5)
Total postoperative 24 h meperidine consumption 164 (22.9)* 120 (25) 118 (24.49)
IT = intrathecal, IV = intravenous.
* Statistically signiﬁcant compared to group II and III (p< 0.05).
Table 5 Perioperative serum magnesium concentrations (mmol/L) at different times of the study {mean (SD)}.
Serum Mg (mmol/L) Group I (control) Group II (IT Mg) Group III (IV Mg) P value
(n= 25) (n= 25) (n= 25)
Preoperative 1.17(0.25) 1.16(0.24) 1.04(0.20) 0.0912
Immediately postoperative 1.024(0.18) 1.29(0.24) 2.16(0.19)* 0.0001
Postoperative 6 h 1.04(0.18) 1.10(0.13) 1.66(0.40)* 0.0001
Postoperative 24 h 0.98(0.13) 1.08(0.14) 1.05(0.21) 0.1167
IT = intrathecal, IV = intravenous.
* Statistically signiﬁcant compared to group I and II.
398 E.M. Samir et al.Intraoperative blood loss was reduced signiﬁcantly among
patients of group III compared to the other 2 groups
(P< 0.0001) (Table 1).
The incidence of nausea and vomiting was insigniﬁcantly
different between the three groups during the study.
Postoperative serumMg in group III was signiﬁcantly high-
er than the other 2 groups immediately postoperative and, at6 h postoperative. Serum Mg levels returned to the normal val-
ues at 24 h postoperative (Table 5).
4. Discussion
This study demonstrated that both i.v infusion of Mg sulfate
and intrathecal Mg during THA surgery under spinal anesthe-
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Intraoperative infusion of Mg sulfate was associated with sig-
niﬁcant reduction in intraoperative MAP and blood loss as
well.
Total hip arthroplasty (THA) has been a major advance for
treatment of chronic arthritis of the hip, providing patients
with pain relief and mobility. Blood loss (related to intraoper-
ative tissue trauma), cardiovascular instability, and postopera-
tive analgesia are major concerns during hip surgery [15].
Seyhan et al. [16] studied the effect of three different doses
of Mg on postoperative consumption of morphine, and a sin-
gle dose of 40 mg kg1 was found to decrease postoperative
morphine consumption, when this dose was followed by a con-
tinuous infusion of 10 mg kg1 h1, the effect was enhanced.
However, increasing the infusion dose to 20 mg kg1 h1 led
to hemodynamic instability without additional analgesic effect.
Perioperative administration of Mg sulfate (50 mg kg1) and
continuous infusion of (15 mg kg1 h1) in gynecology patients
receiving total i.v anesthesia decreased rocuronium require-
ments and improved postoperative analgesia without signiﬁ-
cant side effects [17,18]. Several studies have investigated the
effect of intrathecal and i.v. Mg as adjuvant to bupivacaine
and fentanyl spinal anesthesia on postoperative pain and anal-
gesic consumption and have shown that both intrathecal and
i.v Mg are safe and prolong the time to ﬁrst analgesic require-
ment [13,19]. Based on the previous studies, we used a bolus
dose of magnesium sulfate (40 mg kg1) and continuous infu-
sion of (15 mg kg1 h1) in group III and a dose of (50 mg)
magnesium sulfate as intrathecal adjuvant to bupivacaine in
group II.
In the present study, intraoperative hemodynamics were
stable in all patients of group I and II. Patients in groups III
had lower intraoperative MAP and blood loss. These results
are in agreement with the previous studies which used Mg sul-
fate infusion as a hypotensive agent during clipping of cerebral
aneurysm, major maxillofacial surgery, and in functional
endoscopic sinus surgery [8,20,21]. Magnesium has been used
in hypertensive patients undergoing cataract surgery under lo-
cal anesthesia, and it was effective in controlling blood pres-
sure during surgery. It has been proved in a previous study
that Magnesium increased cerebral blood ﬂow velocity which
has a beneﬁcial effect during hypotensive anesthesia technique
[22,23].
In the current study, insigniﬁcant differences were recorded
between the three study groups as regard the onset, the maxi-
mum sensory level achieved, as well as the onset and duration
of motor blockade. These results are in accordance with the re-
sults of a previous study which reported that concomitant
intrathecal administration of MgSO4 with bupivacaine in pa-
tients undergoing cesarean section did not reduce the onset
time of sensory and motor blockade or prolong the duration
of spinal anesthesia [24]. Hwang et al. [13] reported similar re-
sults with i.v. infusion of Mg sulfate as regard the height of
spinal block.
VAS scores and total meperidine consumption in the ﬁrst
24 h postoperative reported in our study were signiﬁcantly
lower in group II and III compared to group I.
Clinical trials have shown conﬂicting results while investi-
gating analgesic efﬁcacy of magnesium. Tramer and colleagues
[25] reported that magnesium supplementation to patients
undergoing lower abdominal surgery has led to 30% reductionin postoperative consumption of morphine. Other clinical
studies [7,26,27] also demonstrated signiﬁcant reduction in
postoperative morphine, fentanyl, and piritramide consump-
tion following uterus, knee, and lumbar surgeries. These re-
sults, however, are in agreement with our results.
The current study results are still in agreement with the
work done by Tauzin et al. [28] who demonstrated that skin
inﬁltration of MgSO4 and ropivacaine for postoperative anal-
gesia after radical retropubic prostatectomy lead to signiﬁcant
reduction in tramadol requirements.
Our results are in line with another study which suggested
that supplementation of spinal anesthesia with intrathecal
and epidural MgSo4 signiﬁcantly reduced postoperative anal-
gesic consumption in patients undergoing orthopedic surgery
[29]. In addition, other investigators have found that i.v. Mg
sulfate administration during lower limb surgery under spinal
anesthesia reduced postoperative pain and total morphine con-
sumption [30].
Our results are partly in accordance with the previous re-
sults [31] where 5 mg kg1 Mg sulfate boluses were given to pa-
tients after spinal anesthesia and followed by a 500 mg h1
infusion or saline for 24 h. Postoperative analgesic consump-
tion was lower in Mg group, while VAS scores were indifferent
in both groups during the ﬁrst 24 h postoperative period. This
could be explained by that Mg dose was insufﬁcient for post-
operative analgesia.
On the other hand, previous reports have suggested that
both i.v. and intrathecal magnesium failed to reduce the sever-
ity of postoperative pain and the cumulative analgesic con-
sumption [11,12,19]. In the ﬁrst study [11], however, fentanyl
was not given for intraoperative analgesia. In the second study
[12], different doses of magnesium have been used. Whereas in
the third study [19], magnesium sulfate 50 mg was added to
low-dose (6 mg) bupivacaine 0.5% plus 10 mcg fentanyl intra-
thecally. Although the exact mechanism of interaction between
the NMDA receptors and opioid antinociception has not been
fully elucidated, magnesium supplementation proved to poten-
tiate the analgesic effect of opioids and delay the development
of tolerance [12].
In the present study, serum Mg concentrations in group III
were signiﬁcantly higher than the other 2 groups, immediately
after surgery and at 6 h postoperative. These high levels, how-
ever, were safely less than the toxic levels (Mg toxicity begins
at serum concentration of 2.5–5 mmol/L, cardiac arrest occurs
at 12.5 mmol/L) [32].
An inverse relationship has been found between the severity
of postoperative pain and serum magnesium level. Accord-
ingly, prevention of perioperative hypomagnesaemia is an
important factor for antinociceptive mechanism [32].5. Conclusion
This study suggested that co-administration of intravenous Mg
sulfate or intrathecal Mg given to patients undergoing spinal
anesthesia for total hip arthroplasty could improve pain con-
trol for the ﬁrst 24 h after surgery. While there was no signif-
icant difference between the two modalities as regard pain
scores, however, i.v. magnesium led to relative hypotension
and decreased blood loss. Further studies are still needed to
verify these results.
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